Adenosine sestamibi SPECT post-infarction evaluation (INSPIRE) trial: A randomized, prospective multicenter trial evaluating the role of adenosine Tc-99m sestamibi SPECT for assessing risk and therapeutic outcomes in survivors of acute myocardial infarction

Journal of Nuclear Cardiology

Volumn 11, Issue 4, 2004, Pages 458-469

  Mahmarian, John J ^a   Shaw, Leslee J ^b   Olszewski, Gerald H ^c   Pounds, Bradley K ^d   Frias, Maria E ^a   Pratt, Craig M ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b Atlanta Cardiovasc Res Institute   (United States)

^c ASTELLAS PHARMA GLOBAL DEVELOPMENT   (United States)

^d BRISTOL MYERS SQUIBB   (United States)

Author keywords

Adenosine; Risk stratification; Single photon tomography

Indexed keywords

ADENOSINE; AMLODIPINE; AMRINONE; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DILTIAZEM; DOBUTAMINE; GLYCERYL TRINITRATE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; MILRINONE; NITRIC ACID DERIVATIVE;

ACUTE HEART INFARCTION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE REVASCULARIZATION; HEART PERFUSION; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

ADENOSINE; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; SURVIVORS; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TREATMENT OUTCOME; UNITED STATES;

EID: 4243052744     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nuclcard.2004.05.003     Document Type: Article

References (40)

1. Andersen H.R. Nielsen T.T. Rasmussen K. et al. for DANAMI-2 Investigators. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction N Engl J Med 349 2003 733-742
2. Zijlstra F. de Boer M.J. Hoorntje J.C. et al. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction N Engl J Med 328 1993 680-684
3. Keeley E.C. Boura J.A. Grines C.L. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials Lancet 361 2003 13-20
4. Ryan T.J. Antman E.M. Brooks N.H. et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction: 1999 update: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). Available from: URL: www.acc.org. Accessed on May 15, 2004
5. Hochman J.S. Sleeper L.A. Webb J.G. et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock N Engl J Med 341 1999 625-634
6. Gibson C.M. Karha J. Murphy S.A. et al. for TIMI Study Group Early and long-term clinical outcomes associated with reinfarction following fibrinolytic administration in the Thrombolysis in Myocardial Infarction trials J Am Coll Cardiol 42 2003 7-16
7. Morrow D.A. Antman E.M. Charlesworth A. et al. TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation. An Intravenous nPA for Treatment of Infarcting Myocardium Early II trial substudy Circulation 102 2000 2031-2037
8. Rogers W.J. Canto J.G. Lambrew C.T. et al. Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 through 1999: the National Registry of Myocardial Infarction 1, 2 and 3 J Am Coll Cardiol 36 2000 2056-2063
9. Terrin M.L. Williams D.O. Kleiman N.S. et al. Two- and three-year results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II clinical trial J Am Coll Cardiol 22 1993 1763-1772
10. Williams D.O. Braunwald E. Knatterud G. et al. TIMI Investigators One-year results of the Thrombolysis in Myocardial Infarction investigation (TIMI) phase II trial Circulation 85 1992 533-542
11. SWIFT (Should We Intervene Following Thrombolysis?) Trial Study Group SWIFT trial of delayed elective intervention v conservative treatment after thrombolysis with anistreplase in acute myocardial infarction BMJ 302 1991 555-560
12. McCullough P.A. O'Neill W.W. Graham M. et al. A prospective randomized trial of triage angiography in acute coronary syndromes ineligible for thrombolytic therapy. Results of the Medicine Versus Angiography in Thrombolytic Exclusion (MATE) Trial J Am Coll Cardiol 32 1998 596-605
13. Boden W.E. O'Rourke R.A. Crawford M.H. et al. Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital (VANQWISH) Trial Investigators N Engl J Med 338 1998 1785-1792
14. Madsen J.K. Grande P. Saunamäki K. et al. on behalf of the DANAMI Study Group Danish multicenter randomized study of invasive versus conservative treatment in patients with inducible ischemia after thrombolysis in acute myocardial infarction (DANAMI) Circulation 96 1997 748-755
15. Dakik H.A. Kleiman N.S. Farmer J.A. et al. Intensive medical therapy versus coronary angioplasty for suppression of myocardial ischemia in survivors of acute myocardial infarction. A prospective, randomized pilot study Circulation 98 1998 2017-2023
16. Sacks F.M. Pfeffer M.A. Moye L.A. et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels N Engl J Med 335 1996 1001-1009
17. The MIAMI Trial Research Group Metoprolol in Acute Myocardial Infarction (MIAMI): a randomized placebo-controlled international trial Eur Heart J 6 1985 199-226
18. The Norwegian Multicenter Study Group Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction N Engl J Med 304 1981 801-807
19. The Danish Study Group on Verapamil in Myocardial Infarction Effect of verapamil on mortality and major events after acute myocardial infarction (the Danish Verapamil Infarction Trial II-DAVIT II) Am J Cardiol 66 1990 779-785
20. Gibson R.S. Boden W.E. Theroux P. et al. the Diltiazem Reinfarction Study Group Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction: Results of a double-blind, randomized, multicenter trial N Engl J Med 315 1986 423-429
21. The Multicenter Diltiazem Postinfarction Trial Research Group The effect of diltiazem on mortality and reinfarction after myocardial infarction N Engl J Med 319 1988 385-392
22. Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Investigators Cannon C.P. Braunwald E. McCabe C.H. et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes N Engl J Med 350 2004 1495-1504
23. Mahmarian J.J. Pratt C.M. Nishimura S. Abreu A. Verani M.S. Quantitative adenosine Tl-201 single-photon emission computed tomography for the early assessment of patients surviving acute myocardial infarction Circulation 87 1993 1197-1210
24. Mahmarian J.J. Mahmarian A.C. Marks G.F. Pratt C.M. Verani M.S. Role of adenosine thallium-201 tomography for defining long-term risk in patients after acute myocardial infarction J Am Coll Cardiol 25 1995 1333-1340
25. Dakik H.A. Farmer J.A. He Z.-X. et al. Quantitative adenosine thallium-201 single photon tomography accurately predicts risk following acute myocardial infarction: the results of a prospective trial [abstract] J Am Coll Cardiol 29Suppl A 1997 228A
26. Alderman E.L. Fisher L.D. Litwin P. et al. Results of coronary artery surgery in patients with poor left ventricular function (CASS) Circulation 68 1983 785-795
27. Chaitman B.R. Fisher L.D. Bourassa M.G. et al. Effect of coronary bypass surgery on survival patterns in subsets of patients with left main coronary artery disease. Report of the Collaborative Study in Coronary Artery Surgery (CASS) Am J Cardiol 48 1981 765-777
28. Mock M.B. Ringqvist I. Fisher L.D. et al. Survival of medically treated patients in the coronary artery surgery study (CASS) registry Circulation 66 1982 562-568
29. Srinivas V.S. Brooks M.M. Detre K.M. et al. Contemporary percutaneous coronary intervention versus balloon angioplasty for multivessel coronary artery disease: a comparison of the National Heart, Lung and Blood Institute Dynamic Registry and the Bypass Angioplasty Revascularization Investigation (BARI) study Circulation 106 2002 1627-1633
30. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) JAMA 285 2001 2486-2497
31. Chobanian A.V. Bakris G.L. Black H.R. et al. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report JAMA 289 2003 2560-2572
32. Mahmarian J.J. Moye L.A. Verani M.S. Bloom M.F. Pratt C.M. High reproducibility of myocardial perfusion defects in patients undergoing serial exercise thallium-201 tomography Am J Cardiol 75 1995 1116-1119
33. FRagmin and Fast Revascularisation during InStability in Coronary artery disease (FRISC II) Investigators Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study Lancet 354 1999 708-715
34. Cannon C.P. Weintraub W.S. Demopoulos L.A. et al. for the TACTICS-Thrombolysis in Myocardial Infarction 18 Investigators: Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban N Engl J Med 344 2001 1879-1887
35. Dakik H.A. Mahmarian J.J. Kimball K.T. et al. Prognostic value of exercise thallium-201 tomography in patients treated with thrombolytic therapy during acute myocardial infarction Circulation 94 1996 2735-2742
36. Travin M.I. Dessouki A. Cameron T. Heller G.V. Use of exercise technetium-99m sestamibi SPECT imaging to detect residual ischemia and for risk stratification after acute myocardial infarction Am J Cardiol 75 1995 665-669
37. Chaitman B.R. McMahon R.P. Terrin M. et al. Impact of treatment strategy on predischarge exercise test in the Thrombolysis in Myocardial Infarction (TIMI) II Trial Am J Cardiol 71 1993 131-138
38. Gibson R.S. Watson D.D. Craddock G.B. et al. Prediction of cardiac events after uncomplicated myocardial infarction: a prospective study comparing predischarge exercise thallium-201 scintigraphy and coronary angiography Circulation 68 1983 321-336
39. Chiamvimonvat V. Goodman S.G. Langer A. Barr A. Freeman M.R. Prognostic value of dipyridamole SPECT imaging in low-risk patients after myocardial infarction J Nucl Cardiol 8 2001 136-143
40. Brown K.A. Heller G.V. Landin R.S. et al. Early dipyridamole 99mTc-sestamibi single photon emission computed tomographic imaging 2 to 4 days after acute myocardial infarction predicts in-hospital and postdischarge cardiac events: comparison with submaximal exercise imaging Circulation 100 1999 2060-2066